It is noteworthy that in a prior study with breast cancer cells, BMAL1 activates the NF-κB signaling pathway by promoting phosphorylation of IκB, recruitment of CBP (CREB binding protein) and acetylation of p65 40. Here, NFKB1 is linked to breast carcinoma.